rs386834050
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_017777.4(MKS1):c.472C>T(p.Arg158*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000275 in 1,454,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_017777.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MKS1 | NM_017777.4 | c.472C>T | p.Arg158* | stop_gained | 5/18 | ENST00000393119.7 | NP_060247.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MKS1 | ENST00000393119.7 | c.472C>T | p.Arg158* | stop_gained | 5/18 | 1 | NM_017777.4 | ENSP00000376827.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000123 AC: 3AN: 244582Hom.: 0 AF XY: 0.00000751 AC XY: 1AN XY: 133102
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1454812Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 2AN XY: 723996
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 04, 2024 | This sequence change creates a premature translational stop signal (p.Arg158*) in the MKS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKS1 are known to be pathogenic (PMID: 19466712, 24886560, 26490104). This variant is present in population databases (rs386834050, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with MKS1-related conditions (PMID: 17397051). ClinVar contains an entry for this variant (Variation ID: 56623). For these reasons, this variant has been classified as Pathogenic. - |
Meckel syndrome, type 1 Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM) | - | - - |
Bardet-Biedl syndrome 13 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 14, 2024 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | The R158X variant in the MKS1 gene has been reported previously in association with Meckel syndrome. (Khaddour et al., 2007; Tallila et al., 2009). In one publication, this variant was confirmed to be on the opposite allele (in trans) with another pathogenic variant (Khaddour et al., 2007). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R158X variant is observed in 2/241314 alleles in large population cohorts (Lek et al., 2016). We interpret R158X as a pathogenic variant. - |
MKS1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 18, 2024 | The MKS1 c.472C>T variant is predicted to result in premature protein termination (p.Arg158*). This variant has been reported in the compound heterozygous state in a fetus with features consistent with Meckel syndrome (Khaddour et al. 2007. PubMed ID: 17397051) and was also reported in the compound heterozygous state in an individual with isolated retinitis pigmentosa who was found to have a mild presentation of Joubert syndrome through molecular testing (Brunetti-Pierri R et al. 2021. PubMed ID: 34359301). Functional studies using HEK293 cells and fibroblasts from the compound heterozygous patient in the Khaddour et al. paper show that these variants result in ciliary defects, deregulation of proteasome, and disrupt Wnt/beta-catenin signaling (Szymanska et al. 2022. PubMed ID: 35170427). This variant is reported in 0.011% of alleles in individuals of East Asian descent in gnomAD. Nonsense variants in MKS1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at